These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 24805358

  • 1. New era of oral anticoagulation for Japanese non-valvular atrial fibrillation patients.
    Hirano T.
    Circ J; 2014; 78(6):1317-9. PubMed ID: 24805358
    [No Abstract] [Full Text] [Related]

  • 2. Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.
    Parry PV, Engh JA.
    Neurosurgery; 2012 Feb; 70(2):N10-1. PubMed ID: 22251978
    [No Abstract] [Full Text] [Related]

  • 3. Intracranial hemorrhage during dabigatran treatment.
    Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.
    Circ J; 2014 Feb; 78(6):1335-41. PubMed ID: 24662438
    [Abstract] [Full Text] [Related]

  • 4. Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
    Eikelboom JW, Hart RG.
    Stroke; 2015 Jan; 46(1):5-6. PubMed ID: 25406147
    [No Abstract] [Full Text] [Related]

  • 5. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 6. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 7. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014 Sep; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 8. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
    Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA.
    Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
    [No Abstract] [Full Text] [Related]

  • 9. Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.
    Aron JL, Gosselin R, Moll S, Arkin CF, Mantha S.
    J Thromb Thrombolysis; 2014 Nov; 37(2):76-9. PubMed ID: 23519385
    [No Abstract] [Full Text] [Related]

  • 10. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 11. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.
    Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA, Greenlee JD.
    Neurosurgery; 2013 Aug 04; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031
    [Abstract] [Full Text] [Related]

  • 12. Removal of dabigatran by hemodialysis.
    Chang DN, Dager WE, Chin AI.
    Am J Kidney Dis; 2013 Mar 04; 61(3):487-9. PubMed ID: 23219111
    [Abstract] [Full Text] [Related]

  • 13. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.
    Stroke; 2015 Jan 04; 46(1):23-30. PubMed ID: 25406148
    [Abstract] [Full Text] [Related]

  • 14. Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
    Hayashi H, Kitoh K, Mitsunami K, Horie M.
    Intern Med; 2012 Jan 04; 51(15):1987-90. PubMed ID: 22864123
    [Abstract] [Full Text] [Related]

  • 15. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med; 2014 Jul 04; 25(6):e73-5. PubMed ID: 24629895
    [No Abstract] [Full Text] [Related]

  • 16. Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Chan PH, Hai JJ, Siu CW.
    Stroke; 2015 Mar 04; 46(3):e72. PubMed ID: 25649808
    [No Abstract] [Full Text] [Related]

  • 17. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Mar 04; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 18. Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Feng X, Huan Y, Lv Y.
    Stroke; 2015 Mar 04; 46(3):e71. PubMed ID: 25649800
    [No Abstract] [Full Text] [Related]

  • 19. Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
    Liu S, Kim CO, Lucyk SN.
    JAMA Intern Med; 2015 Jul 04; 175(7):1244-5. PubMed ID: 26146920
    [No Abstract] [Full Text] [Related]

  • 20. Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
    Henriksen DP, Hansen MR, Damkier P.
    JAMA Intern Med; 2015 Jul 04; 175(7):1245. PubMed ID: 26146921
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.